{"name":"Medicare Part D spending on GLP-1 drugs, 2020 to 2024","statistic":"Medicare Part D spent $27.5 billion on GLP-1 drugs in 2024, up from $7.0 billion in 2020, according to CMS Medicare Part D Spending by Drug data updated June 25, 2026.","figure":"$27.5B","figure_label":"Part D GLP-1 spending, 2024, before rebates","source_as_of":"2026-06-25","source_as_of_label":"CMS data updated","read":"2026-10-04","temporal_coverage":"2020-01-01/2024-12-31","page":"https://pricetrackerglp1.com/data/medicare-part-d-glp1-spending","license":"CC BY 4.0: cite PriceTracker GLP-1, pricetrackerglp1.com","license_url":"https://creativecommons.org/licenses/by/4.0/","based_on":["https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug","https://data.cms.gov/sites/default/files/2026-06/98218f98-166c-4723-8438-c344a4ef96a6/DSD_PTD_RY26_P04_V10_DY24_BGM.csv"],"method":{"computed":"Sum of \"Total Spending\" for each year across every GLP-1 brand's \"Overall\" row (all manufacturers combined) in CMS's Medicare Part D Spending by Drug dataset, data year 2024.","include":["Brands: Ozempic, Mounjaro, Trulicity, Rybelsus, Wegovy, Bydureon Bcise, Victoza 3-Pak, Victoza 2-Pak, Liraglutide, Byetta, Zepbound."],"exclude":["Insulin combinations: Soliqua (insulin glargine and lixisenatide); Xultophy (insulin degludec and liraglutide).","Beneficiaries are not summed across brands: one person can fill two brands in a year."],"caveats":["Spending is gross drug cost (what plans and patients paid pharmacies), before manufacturer rebates and discounts.","Medicare Part D does not cover drugs prescribed for weight loss alone; most of this spending is for type 2 diabetes, with Wegovy and Zepbound covered for other approved uses.","CMS flags a brand-year as an outlier when its average spending per unit looks unusual: Wegovy 2023."]},"columns":[{"key":"brand","label":"Brand","type":"text"},{"key":"generic","label":"Generic","type":"text"},{"key":"spending_2020_usd","label":"2020","type":"usd"},{"key":"spending_2021_usd","label":"2021","type":"usd"},{"key":"spending_2022_usd","label":"2022","type":"usd"},{"key":"spending_2023_usd","label":"2023","type":"usd"},{"key":"spending_2024_usd","label":"2024 spending","type":"usd"},{"key":"claims_2024","label":"Claims","type":"int"},{"key":"beneficiaries_2024","label":"Beneficiaries","type":"int"},{"key":"avg_per_beneficiary_2024_usd","label":"Per beneficiary","type":"usd"}],"rows":[{"brand":"Ozempic","generic":"Semaglutide","spending_2020_usd":1455812267,"spending_2021_usd":2621694348,"spending_2022_usd":4628160643,"spending_2023_usd":9194048435,"spending_2024_usd":12970296347,"claims_2024":10417182,"beneficiaries_2024":1952637,"avg_per_beneficiary_2024_usd":6642},{"brand":"Mounjaro","generic":"Tirzepatide","spending_2020_usd":null,"spending_2021_usd":null,"spending_2022_usd":144035152,"spending_2023_usd":2361384157,"spending_2024_usd":6336942641,"claims_2024":5105397,"beneficiaries_2024":894581,"avg_per_beneficiary_2024_usd":7084},{"brand":"Trulicity","generic":"Dulaglutide","spending_2020_usd":3284873062,"spending_2021_usd":4702174724,"spending_2022_usd":6225291668,"spending_2023_usd":7363856224,"spending_2024_usd":5454134725,"claims_2024":4305141,"beneficiaries_2024":788716,"avg_per_beneficiary_2024_usd":6915},{"brand":"Rybelsus","generic":"Semaglutide","spending_2020_usd":73444409,"spending_2021_usd":454563823,"spending_2022_usd":974894470,"spending_2023_usd":1665906943,"spending_2024_usd":1890082026,"claims_2024":1251733,"beneficiaries_2024":309993,"avg_per_beneficiary_2024_usd":6097},{"brand":"Wegovy","generic":"Semaglutide","spending_2020_usd":null,"spending_2021_usd":null,"spending_2022_usd":null,"spending_2023_usd":199774,"spending_2024_usd":301283291,"claims_2024":211575,"beneficiaries_2024":52961,"avg_per_beneficiary_2024_usd":5689},{"brand":"Bydureon Bcise","generic":"Exenatide Microspheres","spending_2020_usd":266160951,"spending_2021_usd":379243467,"spending_2022_usd":355078758,"spending_2023_usd":284056759,"spending_2024_usd":215354678,"claims_2024":178931,"beneficiaries_2024":38059,"avg_per_beneficiary_2024_usd":5658},{"brand":"Victoza 3-Pak","generic":"Liraglutide","spending_2020_usd":1545815415,"spending_2021_usd":1422292583,"spending_2022_usd":1238594872,"spending_2023_usd":1004635145,"spending_2024_usd":203063050,"claims_2024":181068,"beneficiaries_2024":62754,"avg_per_beneficiary_2024_usd":3236},{"brand":"Victoza 2-Pak","generic":"Liraglutide","spending_2020_usd":349476159,"spending_2021_usd":334897957,"spending_2022_usd":319205509,"spending_2023_usd":317213565,"spending_2024_usd":77832721,"claims_2024":108521,"beneficiaries_2024":41126,"avg_per_beneficiary_2024_usd":1893},{"brand":"Liraglutide","generic":"Liraglutide","spending_2020_usd":null,"spending_2021_usd":null,"spending_2022_usd":null,"spending_2023_usd":null,"spending_2024_usd":48095824,"claims_2024":62254,"beneficiaries_2024":24405,"avg_per_beneficiary_2024_usd":1971},{"brand":"Byetta","generic":"Exenatide","spending_2020_usd":47676632,"spending_2021_usd":37988662,"spending_2022_usd":27500961,"spending_2023_usd":20645626,"spending_2024_usd":15877480,"claims_2024":11712,"beneficiaries_2024":3043,"avg_per_beneficiary_2024_usd":5218},{"brand":"Zepbound","generic":"Tirzepatide","spending_2020_usd":null,"spending_2021_usd":null,"spending_2022_usd":null,"spending_2023_usd":null,"spending_2024_usd":387343,"claims_2024":353,"beneficiaries_2024":245,"avg_per_beneficiary_2024_usd":1581}]}